References
- Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: Impact on bone metabolism, bone density, and adrenal function. Pediatrics. 2003;111(2):376–383.
- Frediani B, Falsetto P, Bisogno S, Baldi F, Acciai C, Filippou G, Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: A 12 month randomized prospective controlled study. J Rheumatol. 2004;31(6):1083–1087.
- Mahajan VK, Sharma NL, Sharma RC, Garg G. Twelve-year clinic-therapeutic experience in pemphigus: A retrospective study of 54 cases. Int J Dermatol. 2005;44(10):821–827.
- Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol. 2005;12(7):550–556.
- Kawasaki Y, Takano K, Isome M, Suzuki J, Suyama K, Kanno H, Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephrotic syndrome. J Nephrol. 2007;20(1):52–56.
- Shahidi-Dadras M, Karami A, Toosy P, Shafiyan A. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris. Arch Iran Med. 2007;10(1):1–6.
- Kanis JA, Adami S. Bone loss in the elderly. Osteoporos Int. 1994;4(suppl 1):59–65.
- Fogelman I, Blake GM. Different approaches to bone densitometry. J Nucl Med. 2000;41(12):2015–2025.
- Baumagartner TA, Strong CH. Conducting and reading research in health and human performance. 2nd edn. New York: McGraw-Hill; 1998.
- Dubois EF, Roder E, Dekhuijen PN, Zwinderman AE, Schweitzer DH. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest. 2000;121(5):1456–1463.
- Lopate G, Pestronk A, Al-Lozi M. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Arch Neurol. 2005;62(2):249–254.
- Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of Grave's ophthalmopathy: Results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab. 2001;86(8):3562–3567.
- Jain R, Kumar B. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. J Dermatol. 2003;30(10):713–718.
- Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: The effect of the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1987;80(1):81–87.
- Sumboonnanonda A, Vonjirad A, Suntornpoch V, Petrarat S. Adrenal function after prednisolone treatment in childhood nephritic syndrome. J Med Assoc Thai. 1994;77(3):126–129.
- Pearce G, Ryan PF, Delmas PD, Tabensky DA, Seeman E. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. Br J Rheumatol. 1998;37(3):292–299.